Aardvark Therapeutics, Inc.
AARD
$11.75
-$0.064-0.54%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 151.26M | 73.66M | 82.36M | 9.99M | |
| Total Receivables | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | 3.29M | 314.00K | 170.00K | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | -- | 160.00K | 136.00K | -- | |
| Total Current Assets | 154.55M | 74.14M | 82.67M | -- | |
|
|
|||||
| Total Current Assets | 154.55M | 74.14M | 82.67M | -- | |
| Net Property, Plant & Equipment | 628.00K | 735.00K | 841.00K | -- | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | 1.84M | 2.64M | 232.00K | -- | |
| Total Assets | 157.03M | 77.51M | 83.74M | -- | |
|
|
|||||
| Total Accounts Payable | 2.56M | 2.30M | 666.00K | -- | |
| Total Accrued Expenses | 3.03M | 2.29M | 1.62M | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | 390.00K | 338.00K | 323.00K | -- | |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | |
| Total Other Current Liabilities | -- | -- | -- | -- | |
| Total Current Liabilities | 5.98M | 4.93M | 2.61M | -- | |
|
|
|||||
| Total Current Liabilities | 5.98M | 4.93M | 2.61M | -- | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | 336.00K | 441.00K | 545.00K | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | 24.00K | 26.00K | -- | -- | |
| Total Liabilities | 6.34M | 5.39M | 3.16M | -- | |
|
|
|||||
| Common Stock & APIC | 218.28M | 3.68M | 3.37M | -- | |
| Retained Earnings | -67.64M | -58.33M | -49.55M | -- | |
| Treasury Stock & Other | 44.00K | -- | -- | -- | |
| Total Common Equity | 150.69M | -54.64M | -46.17M | -34.80M | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | 126.76M | 126.76M | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | 126.76M | 126.76M | 43.90M | |
|
|
|||||
| Total Common Equity | 150.69M | -54.64M | -46.17M | -34.80M | |
| Total Preferred Equity | -- | 126.76M | 126.76M | 43.90M | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 150.69M | 72.11M | 80.58M | 9.10M | |
|
|
|||||